Company Profiles

driven by the PitchBook Platform

Armetheon

Description

Developer of novel anticoagulants and antibiotics designed to treat cardiovascular disease. The company is developing anti-arrhythmic drug candidate, for the treatment of ventricular tachycardia (VT) in patients with implantable cardioverter defibrillators (ICDs) by addressing major unmet needs in cardiovascular disease, initially in thrombosis and cardiac arrhythmias.

2011

Founded

PRIVATE

Status

11-50

Employees

M&A

Latest Deal Type

$31.6M

Total Amount Raised

11

Investors

Description

Developer of novel anticoagulants and antibiotics designed to treat cardiovascular disease. The company is developing anti-arrhythmic drug candidate, for the treatment of ventricular tachycardia (VT) in patients with implantable cardioverter defibrillators (ICDs) by addressing major unmet needs in cardiovascular disease, initially in thrombosis and cardiac arrhythmias.

Website:

www.armetheon.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

325 Sharon Park Drive Suite 303 Menlo Park, CA 94025United States +1 (650) 646-3898
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Armetheon's full profile, request a free trial.

Armetheon Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Armetheon Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Armetheon Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Amkey VenturesVenture CapitalMinority000 0000000 0000
AshHill BiomedicalVenture CapitalMinority000 0000000 0000
Atheneos Capital ManagementAccelerator/IncubatorMinority000 0000000 0000
Capital TEN IIVenture CapitalMinority000 0000000 0000
CDIB Capital GroupVenture CapitalMinority000 0000000 0000
Amkey Ventures Venture Capital
AshHill Biomedical Venture Capital
Atheneos Capital Management Accelerator/Incubator
Capital TEN II Venture Capital
CDIB Capital Group Venture Capital

Armetheon Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Muralitharan Kengatharan Ph.DCo-Founder, President, Co-Chief Executive Officer & Director
Pascal Druzgala Ph.DCo-Founder, Board Member, Senior Vice President, Research & Chief Scientific Officer
Elizabeth Ahrens JDGeneral Counsel & Vice President, Legal
Detlef Albrecht MDChief Medical Officer & Head of Drug Development
Lisa StemmerichVice President, Human Resources
Muralitharan Kengatharan Ph.D Co-Founder, President, Co-Chief Executive Officer & Director
Pascal Druzgala Ph.D Co-Founder, Board Member, Senior Vice President, Research & Chief Scientific Officer
Elizabeth Ahrens JD General Counsel & Vice President, Legal
Detlef Albrecht MD Chief Medical Officer & Head of Drug Development
Lisa Stemmerich Vice President, Human Resources

Armetheon Board Members (2)

NameRepresentingRoleSinceContact
Info
John Saxe JDSelfDirector000 0000
Peter Milner MDSelfCo-Founder & Executive Chairman000 0000
John Saxe JD Director Self
Peter Milner MD Co-Founder & Executive Chairman Self
Request full access to PitchBook